Detalhe da pesquisa
1.
BPRS domains, items and subgroups analyses, and CGI-I ratings in pooled data from non-interventional studies of aripiprazole once-monthly in schizophrenia (REACT study).
BMC Psychiatry
; 23(1): 162, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918846
2.
Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study).
BMC Psychiatry
; 23(1): 383, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259053
3.
The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index.
BMC Psychiatry
; 20(1): 77, 2020 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087718
4.
[Early Intervention in Schizophrenia - an Update]. / Frühintervention bei Schizophrenie ein Update.
Fortschr Neurol Psychiatr
; 88(6): 387-397, 2020 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-32557467
5.
[Motivational interviewing : A possibility for doctor-patient communication in schizophrenia?] / "Motivational interviewing" : Eine Möglichkeit der Arzt-Patienten-Kommunikation bei Schizophrenie?
Nervenarzt
; 90(11): 1144-1153, 2019 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-30941459
6.
[Quality of life as a target criterion in schizophrenia therapy]. / Lebensqualität als Zielkriterium in der Schizophrenietherapie.
Fortschr Neurol Psychiatr
; 87(6): 348-356, 2019 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-30541162
7.
Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study.
BMC Psychiatry
; 18(1): 389, 2018 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30551736
8.
Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study.
BMC Psychiatry
; 18(1): 365, 2018 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30428862
9.
[Early Intervention in Schizophrenia - an Update]. / Frühintervention bei Schizophrenie ein Update.
Fortschr Neurol Psychiatr
; 88(6): e1, 2020 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-32785908
10.
Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly.
Schizophrenia (Heidelb)
; 9(1): 80, 2023 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935711
11.
Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD.
Int J Geriatr Psychiatry
; 27(6): 651-6, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22513699
12.
Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies.
Eur Psychiatry
; 65(1): e42, 2022 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35855645
13.
Measuring therapeutic efficacy in patients with Alzheimer's disease: role of instruments.
Dement Geriatr Cogn Disord
; 31(3): 233-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21474932
14.
Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly.
Schizophr Res
; 260: 183-190, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683508